Knowledge Desk
European Society of Cardiology Guidelines 2023
The current issue of The Scientific Times (Volume 28, Year 2023) features key aspects of the 2023 update of the European Society of Cardiology (ESC) guidelines, which primarily focus on the management of cardiovascular diseases in individuals with diabetes.
T2DM Guidelines by American Association of Clinical Endocrinology (AACE) 2023
The American Association of Clinical Endocrinology (AACE) 2023 issued a consensus statement in the Management of Type 2 Diabetes. It provides visual guidance in concise graphic algorithms to assist with clinical decision-making of health care professionals in the management of persons with T2DM to improve patient care. The current issue of The Scientific Times highlights the guidelines recommended by AACE 2023.
T2DM Guidelines by American Association of Clinical Endocrinology (AACE) 2023
The Scientific Times- 2022 Guidelines & SGLT2 Inhibitors
The latest editions of 2022 AHA/ACC/HFSA guideline for the management of heart failure and KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease, have many new practice-changing twists in the management of these conditions. Based on new evidence, SGLT2i is now recommended in all stages & types of HF as an adjunct to the standard of care in the management of HF patients with or without diabetes. Many break-through trials of SGLT2i in CKD patients with or without diabetes conferred the benefits of SGLT2i in these patients.
The Scientific Times- 2022 Guidelines & SGLT2 Inhibitors
The Scientific Times- National Family Health Survey
The Scientific Times_National Family Health Survey-5
ACC Cardiology session 2021
The American College of Cardiology (ACC) 70th Annual Scientific Session & Expo was conducted virtually in the month of May with the theme of “reFocus on Science and reConnect with Patient Care.”
The latest cardiology practice-changing scientific breakthrough, late-breaking studies were discussed in the meeting. The Scientific Times includes the highlights of the key landmark trials discussed in the latest ACC 2021 scientific conference.
Probiotic Power for Pediatric Diarrhea
Acute diarrhea is the most frequent gastrointestinal disorder and the main cause of dehydration in childhood. Acute diarrhea causes substantial complications and is the second leading cause of death worldwide in children younger than 5 years of age.
Diarrhea whether infectious or non-infectious, is associated with intestinal dysbiosis which contributes to the severity of the disease. Hence, in addition to fluid replacement, replenishing the disturbed gut microbiota and maintaining healthy gut state is imperative for treating diarrhea.
LGGTM has been the most studied probiotic strain in children and has shown to be effective against pediatric diarrhea of different etiologies. LGGTM have been documented in a large number of clinical trials. These studies demonstrate its beneficial effects like shortening the duration of diarrhea, reducing the number of diarrhea episodes, and reducing the severity of symptoms.
In this E-circular, we have incorporated the flipbook format which is an interactive graphic design that conveys the information in easy and impactful way.
AHA Scientific Statement _Psychological Health & CV Health
The psychological health can positively or negatively impact a person’s health and risk factors for heart disease and stroke. For the first time American Heart Association (AHA) issued a scientific statement focusing on Psychological Health, Well-Being, and the Mind–Heart–Body Connection that more broadly addresses the issue of psychological health. Kindly find attached The Scientific Times which includes the key highlights of this latest AHA Scientific Statement.
ADA Guidelines 2021
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes,” is intended to provide clinicians, patients, researchers, policy makers, and other interested individuals with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care.
The 2021 Standards of Medical Care in Diabetes provides the latest comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2 or gestational diabetes; strategies for the prevention or delay of type 2 diabetes; and therapeutic approaches that can reduce complications, mitigate cardiovascular and renal risk, and improve health outcomes.
This year due to COVID pandemic the European Society of Cardiology (ESC) moves 100% online, for the first time in its 70-year history, to create ESC Congress 2020, Challenging Times, Infinite Possibilities. It was held virtually from 29 Aug to 1 Sep 2020.
The meeting was a scientific feast with the scientific program addressing various aspects of cardiovascular diseases covering clinical practice guidelines and number of landmark trials. Kindly find attached The Scientific Times including some of the key highlights from the same.
ACC Expert Consensus Decision Pathway (ECDP) 2020
There has been evolution in the care that can be provided to patients with
type 2 diabetes (T2D) and cardiovascular disease (CVD) because of the number of new therapies with established cardiovascular benefit.
In view of the same, panel of experts from American College of Cardiology (ACC) have collated the range of treatment recommendations based on the current evidences and released in the form of an Expert Consensus Decision Pathway (ECDP) in August 2020.
ACC Expert Consensus Decision Pathway
The Scientific Times volume-7 (World Digestive Health Day)
The Scientific Times Volume-7
The Scientific Times volume-6
The Scientific Times Volume-5 (COVID-19)
The Scientific Times volume-4
The Scientific Times Volume-3
The Scientific Times volume-2
The Scientific Times Vol-2(EASD 2019 Highlights)
The Scientific Times volume-1
The Scientific Times ESC Congress 2019 Highlights
The Scientific Times_2021
WHO hypertension guidelines
Standards of Medical Care in Diabetes (ADA Guidelines 2023)
The 2023 Standards of Medical Care in Diabetes (ADA Guidelines 2023) provides the latest comprehensive, evidence-based recommendations for diabetes management, including updates in cardiovascular disease, weight management, CKD, and introduction of newer agents for diabetes and its complication management.
Standards of Medical Care in Diabetes (ADA Guidelines 2023)
The 2023 Standards of Medical Care in Diabetes (ADA Guidelines 2023) provides the latest comprehensive, evidence-based recommendations for diabetes management, including updates in cardiovascular disease, weight management, CKD, and introduction of newer agents for diabetes and its complication management.